Lines drawn on comparing medical treatments
The Obama administration plans to spend $1.1 billion over the next few years on studies to compare the effectiveness of competing treatments for common conditions like back pain, heart disease, and prostate cancer. The studies will be publicly released, to help doctors and patients decide which treatment options they want to pursue. Supporters include many medical researchers, consumer groups, unions, and insurers. But potential opponents warn that the comparative effectiveness movement could lead to inadequate treatment for some patients and even the rationing of healthcare.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- 3 Traits Personality Assessments Can't Reveal
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Carondelet to Pay $35M to Settle Fraud Allegations
- CHS Hacked, 4.5M Patient Records Compromised